TY  - JOUR
AU  - Melero-Jerez, Carolina
AU  - Suardíaz, Margarita
AU  - Lebrón-Galán, Rafael
AU  - Marín-Bañasco, Carmen
AU  - Oliver-Martos, Begoña
AU  - Machín-Díaz, Isabel
AU  - Fernández, Óscar
AU  - de Castro, Fernando
AU  - Clemente, Diego
PY  - 2019
DO  - 10.1016/j.nbd.2019.02.014
UR  - http://hdl.handle.net/10668/13618
T2  - Neurobiology of disease
AB  - Multiple sclerosis (MS) is an autoimmune demyelinating disease of the human central nervous system (CNS), mainly affecting young adults. Among the immunomodulatory disease modifying treatments approved up to date to treat MS, IFN-β remains to be one...
LA  - en
KW  - Arginase-I
KW  - EAE
KW  - IFN-β
KW  - Immunomodulation
KW  - Immunosuppression
KW  - Inflammation
KW  - Remyelination
KW  - Animals
KW  - Encephalomyelitis, Autoimmune, Experimental
KW  - Immunosuppressive Agents
KW  - Interferon-beta
KW  - Mice
KW  - Myeloid-Derived Suppressor Cells
TI  - The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis.
TY  - research article
VL  - 127
ER  -